Cure My Disease

Don't miss your cure!

 Log in / Sign up

Zapping away shingles pain: new trial tests pulsed radiofrequency

NCT ID NCT07390279

Recruiting now Symptom relief Sponsor: Prof. Dr. Cemil Tascıoglu Education and Research Hospital Organization Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tests whether a noninvasive procedure called transcutaneous pulsed radiofrequency can reduce chronic pain from postherpetic neuralgia, a complication of shingles. The procedure delivers electrical pulses through electrodes placed on the skin over the painful area. Researchers will enroll 35 adults with this condition to measure changes in pain intensity and nerve pain symptoms.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
Transcutaneous pulsed radiofrequency (a noninvasive procedure using electrical pulses over the painful area)
What this could lead to
If it works, this could offer a new, noninvasive option to reduce chronic pain from shingles without drugs or injections.
What could go wrong
This is a small, early-stage trial with only 35 people, so results may not apply to everyone. The procedure may not provide lasting pain relief.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for CHRONIC PAIN are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

Chronic Pain chronic pain syndrome Neuralgia, Postherpetic peripheral neuropathy postherpetic neuralgia

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

CHRONIC PAIN NEUROPATHY POSTHERPETIC NEURALGIA

Contacts and locations

Locations

  • Istanbul Prof. Dr. Cemil Taşcioğlu City Hospital

    RECRUITING

    Istanbul, Istanbul, 34000, Turkey (Türkiye)

More trials for these conditions

Other studies related to the condition(s) this trial covers.